PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97343274 |
Filing Date: 04/01/2022 |
Input Field |
Entered |
SERIAL NUMBER | 97343274 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\973\432\97343274\xml1 \ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | JOENJA LENIOLISIB |
COLOR MARK | YES |
COLOR(S) CLAIMED (If applicable) |
The color(s) purple and orange is/are claimed as a feature of the mark. |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of an image of an infinity symbol made up of various sizes of purple and orange circles appearing over the word Joenja in purple font which appears over the word leniolisib in orange font. |
PIXEL COUNT ACCEPTABLE | YES |
PIXEL COUNT | 852 x 450 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Pharming Intellectual Property B.V. |
*MAILING ADDRESS | Darwinweg 24 |
*CITY | Leiden |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Netherlands |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
2333CR |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | besloten vennootschap (b.v.) |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED | Netherlands |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Pharmaceutical preparations for the treatment of immune system related diseases and disorders |
FILING BASIS | SECTION 1(b) |
FILING BASIS | SECTION 44(d) |
FOREIGN APPLICATION NUMBER | 18678491 |
FOREIGN APPLICATION COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
European Union Trademark - EUTM |
FOREIGN FILING DATE | 03/28/2022 |
INTENT TO PERFECT 44(d) |
At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for registration, a valid claim of priority may be retained. |
ATTORNEY INFORMATION | |
NAME | Mark D. Passler |
ATTORNEY DOCKET NUMBER | 12093-12 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | AKERMAN LLP |
INTERNAL ADDRESS | Suite 1100, West Tower |
STREET | 777 S. Flagler Drive |
CITY | West Palm Beach |
STATE | Florida |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 33401 |
PHONE | 561-653-5000 |
FAX | 561-659-6313 |
EMAIL ADDRESS | ip@akerman.com |
OTHER APPOINTED ATTORNEY | Peter A. Chiabotti; Ryan L. Harding; Brice S. Dumais; J. Andre Cortes; Victoria Doyle; Caroline H. Mankey; Kourtney A. Mulcahy |
CORRESPONDENCE INFORMATION | |
NAME | Mark D. Passler |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | ip@akerman.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /Mark D. Passler/ |
SIGNATORY'S NAME | Mark D. Passler |
SIGNATORY'S POSITION | Attorney of Record |
SIGNATORY'S PHONE NUMBER | 561-653-5000 |
DATE SIGNED | 04/01/2022 |
SIGNATURE METHOD | Signed directly within the form |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97343274 |
Filing Date: 04/01/2022 |
The applicant's current Correspondence Information: |
Mark D. Passler |
PRIMARY EMAIL FOR CORRESPONDENCE: ip@akerman.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|